Clinical trial
Predicting Development of Sub-Clinical Atrial Fibrillation in Device Patients
NCT02808260 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Development of Sub-Clinical Atrial Fibrillation in Device Patients
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- September 30, 2034
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.